Sandro Pignata

36.2k citations
439 papers · 10.7k · 5 hit papers · h-index 51

Impact in

Papers in

    • Ovarian cancer diagnosis and treatment 183
    • PARP inhibition in cancer therapy 74
    • Cancer Immunotherapy and Biomarkers 45

Sandro Pignata

404 papers receiving 10.5k citations

Sandro Pignata's Hit Papers

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study 2023 · 242 citations
2420+9+18Years since publication250500750

Peers

Sandro Pignata
Comparison fields: 5 of 140
  • Reproductive Medicine 3.2k
  • Obstetrics and Gynecology 1.5k
  • Oncology 3.4k
  • Hepatology 919
  • Cancer Research 974
Replace Jonathan A. Ledermann with:
Jonathan A. Ledermann United Kingdom
Robert A. Burger United States
S. Diane Yamada United States
Carol Aghajanian United States
Hal W. Hirte Canada
Christian Marth Austria
Byoung‐Gie Kim South Korea
Mark F. Brady United States
Scott Wadler United States
Anders Jakobsen Denmark
Sandro Pignata relative to Jonathan A. Ledermann United Kingdom Jonathan A. Ledermann's profile →
Citations per field
00.5×1.5×
Jonathan A. Ledermann · 1×
Citations per year

Countries citing papers authored by Sandro Pignata

Since Specialization
Citations

This map shows the geographic impact of Sandro Pignata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandro Pignata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandro Pignata more than expected).

Fields of papers citing papers by Sandro Pignata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandro Pignata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandro Pignata. The network helps show where Sandro Pignata may publish in the future.

Co-authors

The 25 scholars most cited alongside Sandro Pignata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sandro Pignata Line = papers co-authored together Sandro Pignata links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 439 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Radiofrequency Ablation of Unresectable Primary and Metastatic Hepatic Malignancies
Hit paper breakdown →
1999856
2
Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
Hit paper breakdown →
2010412
3
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer
Hit paper breakdown →
2018345
4 2004292
5
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
Hit paper breakdown →
2019273
6
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
Hit paper breakdown →
2023242
7 2017235
8 2020223
9 2008222
10 2018156
11 2013151
12 2010126
13 2017119
14 2004116
15 2016115
16 2013108
17 2018104
18 2009102
19 2019102
20 200699

About Sandro Pignata

Sandro Pignata is a scholar working on Reproductive Medicine, Oncology, Pulmonary and Respiratory Medicine, Obstetrics and Gynecology and Surgery, having authored 439 papers that have together received 10.7k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (183 papers), Endometrial and Cervical Cancer Treatments (75 papers), PARP inhibition in cancer therapy (74 papers), Cancer Immunotherapy and Biomarkers (45 papers), Renal cell carcinoma treatment (36 papers), Cancer Genomics and Diagnostics (27 papers), BRCA gene mutations in cancer (27 papers) and Bladder and Urothelial Cancer Treatments (18 papers). The work is most often cited by research in Reproductive Medicine (3.2k citations), Obstetrics and Gynecology (1.5k citations), Oncology (3.4k citations), Hepatology (919 citations) and Cancer Research (974 citations). Sandro Pignata has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Bruno Daniele, Carmela Pisano, Sabrina Chiara Cecere, Giovanni Scambia, Francesco Izzo, Francesco Fiore, Paolo Vallone, Domenica Lorusso, Nicoletta Colombo and Andreas du Bois. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, International Journal of Gynecological Cancer, Gynecologic Oncology and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact